Biogen Update: Bioverativ Spinoff….

Just a heads up for readers: today Biogen spun off its hemophilia unit — Bioverativ. Given the revenues that Bioverativ generated, the marketplace adjusts the parent company stock price to reflect the spin off. Hence, while Biogen’s price is significantly…continue reading